Advancing therapeutic strategies for inherited retinal degeneration

Recommendations from the monaciano symposium

Debra A. Thompson, Robin R. Ali, Eyal Banin, Kari E. Branham, John G. Flannery, David M. Gamm, William W. Hauswirth, John R. Heckenlively, Alessandro Iannaccone, K. Thiran Jayasundera, Naheed W. Khan, Robert S. Molday, Mark Pennesi, Thomas A. Reh, Richard Weleber, David N. Zacks

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Although rare in the general population, retinal dystrophies occupy a central position in current efforts to develop innovative therapies for blinding diseases. This status derives, in part, from the unique biology, accessibility, and function of the retina, as well as from the synergy between molecular discoveries and transformative advances in functional assessment and retinal imaging. The combination of these factors has fueled remarkable progress in the field, while at the same time creating complex challenges for organizing collective efforts aimed at advancing translational research. The present position paper outlines recent progress in gene therapy and cell therapy for this group of disorders, and presents a set of recommendations for addressing the challenges remaining for the coming decade. It is hoped that the formulation of these recommendations will stimulate discussions among researchers, funding agencies, industry, and policy makers that will accelerate the development of safe and effective treatments for retinal dystrophies and related diseases.

Original languageEnglish (US)
Pages (from-to)918-931
Number of pages14
JournalInvestigative Ophthalmology and Visual Science
Volume56
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Retinal Dystrophies
Retinal Degeneration
Investigational Therapies
Translational Medical Research
Cell- and Tissue-Based Therapy
Administrative Personnel
Genetic Therapy
Retina
Industry
Research Personnel
Therapeutics
Population

Keywords

  • Cell therapy
  • Disease phenotypes
  • Gene therapy
  • Outcome Measures
  • Retinal dystrophy

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience
  • Medicine(all)

Cite this

Thompson, D. A., Ali, R. R., Banin, E., Branham, K. E., Flannery, J. G., Gamm, D. M., ... Zacks, D. N. (2015). Advancing therapeutic strategies for inherited retinal degeneration: Recommendations from the monaciano symposium. Investigative Ophthalmology and Visual Science, 56(2), 918-931. https://doi.org/10.1167/iovs.14-16049

Advancing therapeutic strategies for inherited retinal degeneration : Recommendations from the monaciano symposium. / Thompson, Debra A.; Ali, Robin R.; Banin, Eyal; Branham, Kari E.; Flannery, John G.; Gamm, David M.; Hauswirth, William W.; Heckenlively, John R.; Iannaccone, Alessandro; Thiran Jayasundera, K.; Khan, Naheed W.; Molday, Robert S.; Pennesi, Mark; Reh, Thomas A.; Weleber, Richard; Zacks, David N.

In: Investigative Ophthalmology and Visual Science, Vol. 56, No. 2, 2015, p. 918-931.

Research output: Contribution to journalArticle

Thompson, DA, Ali, RR, Banin, E, Branham, KE, Flannery, JG, Gamm, DM, Hauswirth, WW, Heckenlively, JR, Iannaccone, A, Thiran Jayasundera, K, Khan, NW, Molday, RS, Pennesi, M, Reh, TA, Weleber, R & Zacks, DN 2015, 'Advancing therapeutic strategies for inherited retinal degeneration: Recommendations from the monaciano symposium', Investigative Ophthalmology and Visual Science, vol. 56, no. 2, pp. 918-931. https://doi.org/10.1167/iovs.14-16049
Thompson, Debra A. ; Ali, Robin R. ; Banin, Eyal ; Branham, Kari E. ; Flannery, John G. ; Gamm, David M. ; Hauswirth, William W. ; Heckenlively, John R. ; Iannaccone, Alessandro ; Thiran Jayasundera, K. ; Khan, Naheed W. ; Molday, Robert S. ; Pennesi, Mark ; Reh, Thomas A. ; Weleber, Richard ; Zacks, David N. / Advancing therapeutic strategies for inherited retinal degeneration : Recommendations from the monaciano symposium. In: Investigative Ophthalmology and Visual Science. 2015 ; Vol. 56, No. 2. pp. 918-931.
@article{d183c00b77024035b07fdaa6da3aa8b8,
title = "Advancing therapeutic strategies for inherited retinal degeneration: Recommendations from the monaciano symposium",
abstract = "Although rare in the general population, retinal dystrophies occupy a central position in current efforts to develop innovative therapies for blinding diseases. This status derives, in part, from the unique biology, accessibility, and function of the retina, as well as from the synergy between molecular discoveries and transformative advances in functional assessment and retinal imaging. The combination of these factors has fueled remarkable progress in the field, while at the same time creating complex challenges for organizing collective efforts aimed at advancing translational research. The present position paper outlines recent progress in gene therapy and cell therapy for this group of disorders, and presents a set of recommendations for addressing the challenges remaining for the coming decade. It is hoped that the formulation of these recommendations will stimulate discussions among researchers, funding agencies, industry, and policy makers that will accelerate the development of safe and effective treatments for retinal dystrophies and related diseases.",
keywords = "Cell therapy, Disease phenotypes, Gene therapy, Outcome Measures, Retinal dystrophy",
author = "Thompson, {Debra A.} and Ali, {Robin R.} and Eyal Banin and Branham, {Kari E.} and Flannery, {John G.} and Gamm, {David M.} and Hauswirth, {William W.} and Heckenlively, {John R.} and Alessandro Iannaccone and {Thiran Jayasundera}, K. and Khan, {Naheed W.} and Molday, {Robert S.} and Mark Pennesi and Reh, {Thomas A.} and Richard Weleber and Zacks, {David N.}",
year = "2015",
doi = "10.1167/iovs.14-16049",
language = "English (US)",
volume = "56",
pages = "918--931",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "2",

}

TY - JOUR

T1 - Advancing therapeutic strategies for inherited retinal degeneration

T2 - Recommendations from the monaciano symposium

AU - Thompson, Debra A.

AU - Ali, Robin R.

AU - Banin, Eyal

AU - Branham, Kari E.

AU - Flannery, John G.

AU - Gamm, David M.

AU - Hauswirth, William W.

AU - Heckenlively, John R.

AU - Iannaccone, Alessandro

AU - Thiran Jayasundera, K.

AU - Khan, Naheed W.

AU - Molday, Robert S.

AU - Pennesi, Mark

AU - Reh, Thomas A.

AU - Weleber, Richard

AU - Zacks, David N.

PY - 2015

Y1 - 2015

N2 - Although rare in the general population, retinal dystrophies occupy a central position in current efforts to develop innovative therapies for blinding diseases. This status derives, in part, from the unique biology, accessibility, and function of the retina, as well as from the synergy between molecular discoveries and transformative advances in functional assessment and retinal imaging. The combination of these factors has fueled remarkable progress in the field, while at the same time creating complex challenges for organizing collective efforts aimed at advancing translational research. The present position paper outlines recent progress in gene therapy and cell therapy for this group of disorders, and presents a set of recommendations for addressing the challenges remaining for the coming decade. It is hoped that the formulation of these recommendations will stimulate discussions among researchers, funding agencies, industry, and policy makers that will accelerate the development of safe and effective treatments for retinal dystrophies and related diseases.

AB - Although rare in the general population, retinal dystrophies occupy a central position in current efforts to develop innovative therapies for blinding diseases. This status derives, in part, from the unique biology, accessibility, and function of the retina, as well as from the synergy between molecular discoveries and transformative advances in functional assessment and retinal imaging. The combination of these factors has fueled remarkable progress in the field, while at the same time creating complex challenges for organizing collective efforts aimed at advancing translational research. The present position paper outlines recent progress in gene therapy and cell therapy for this group of disorders, and presents a set of recommendations for addressing the challenges remaining for the coming decade. It is hoped that the formulation of these recommendations will stimulate discussions among researchers, funding agencies, industry, and policy makers that will accelerate the development of safe and effective treatments for retinal dystrophies and related diseases.

KW - Cell therapy

KW - Disease phenotypes

KW - Gene therapy

KW - Outcome Measures

KW - Retinal dystrophy

UR - http://www.scopus.com/inward/record.url?scp=84922552776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922552776&partnerID=8YFLogxK

U2 - 10.1167/iovs.14-16049

DO - 10.1167/iovs.14-16049

M3 - Article

VL - 56

SP - 918

EP - 931

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 2

ER -